Cite
MLA Citation
Louise Emmett et al.. “ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer treated with enzalutamide (ANZUP 1901).” BJU international, vol. 128, 2021, pp. 642–651. http://access.bl.uk/ark:/81055/vdc_100144748482.0x00002b